Vaccine

Heart health after COVID-19 infection compared to Pfizer vaccine in teens and young adults: a study of 4 million people

mRNA Technology Weekly Brief ↗PubMed ↗DOI ↗

Updated

Abstract

Concerns about myocarditis and mortality after COVID-19 vaccination in pediatrics remain relevant.

  • Myocarditis and pericarditis risks may differ between COVID-19 infection and BNT162b2 vaccination.
  • Limited direct comparisons are available regarding these risks in adolescents and young adults.
  • Mortality rates associated with myocarditis after vaccination versus infection are not fully understood.

Simplified

Full Text

Full text is available at the source.
View Full Text ↗

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free

Recent issues from the mrna technology brief

issue #57
AI found a thermostable mRNA vaccine formula in one month that survives 37°C for two months
yesterday7 studies
issue #56
A microfluidics trick reorganized mRNA nanoparticles and cut tumor growth by 89% in mice
1 week ago7 studies
issue #55
An mRNA drug wiped out B cells in 3 patients with an autoimmune blood disorder — without cytokine release syndrome
2 weeks ago7 studies
issue #54
New 'charge-switching' lipid nanoparticles deliver RNA without triggering inflammation
3 weeks ago7 studies
issue #53
A cold-adapted viral enzyme makes cleaner mRNA with almost no inflammatory byproduct
4 weeks ago7 studies
issue #52
An mRNA treatment restored liver protein and improved disease markers in mice
5 weeks ago7 studies
issue #51
A synchronized STING vaccine suppressed tumor growth without triggering systemic immune chaos
6 weeks ago7 studies
issue #50
New LNPs crossed the blood-brain barrier in primates and cut stroke damage in rats
7 weeks ago7 studies
issue #49
A single antibody-coated nanoparticle edits blood stem cells inside living mice
8 weeks ago7 studies
issue #48
A new RNA polymerase makes self-amplifying vaccine production 9x easier
9 weeks ago7 studies
explore the archive
See more issues from the mrna technology brief